ALPHA TAU MEDICAL LTD DRTS
ORDINARY SHARES · Common Stock · CUSIP M0740A108
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $4.33.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 19 |
| Q4 2022 | 15 |
| Q1 2023 | 17 |
| Q2 2023 | 21 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 5 | 10 |
| Q1 2023 | 8 | 5 |
| Q2 2023 | 10 | 3 |
Biggest buyers
| CITIGROUP INC | Added | +313.7k |
| Corbin Capital Partners, L.P. | New | +260.1k |
| Atalaya Capital Management LP | New | +73.7k |
| Grey Street Capital, LLC | New | +23.3k |
| MORGAN STANLEY | Added | +21.7k |
| LEVIN CAPITAL STRATEGIES, L.P. | New | +20.0k |
| Tuttle Capital Management, LLC | New | +12.2k |
| Summit Trail Advisors, LLC | New | +10.3k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +6.5k |
| Activest Wealth Management | New | +4.1k |
Biggest sellers
| FMR LLC | Sold out | -724.1k |
| JPMORGAN CHASE & CO | Reduced | -19.4k |
| UBS Group AG | Sold out | -1.3k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
ORAMED PHARMACEUTICALS INC.
13D · may seek influence
new · filed 2025-05-01
Stated purposeShare Purchase Agreement On April 24, 2025, Oramed Ltd. entered into a Share Purchase Agreement (the "Purchase Agreement") with the Issuer for the purchase by Oramed Ltd. of 14,110,121 Ordinary Shares of the Issuer, in a registered direct offering (the "Offering"), at a purchase price of $2.612 per share. The aggregate purchase price paid for the Ordinary Shares of the Issuer was approximately $36.9 million, prior to the Issuer's deduction of estimated offering expenses payable by the Issuer. The closing of the Offering occurred on April 28, 2025 (the "Closing Date"). The Purchase Agreement contains customary representations, warranties and agreements by the Issuer and Oramed Ltd., customary conditions to closing, indemnification obligations of the Issuer, other obligations of the partie… Full filing |
20.0% |
| Sofer Uzi 13G · exempt (held before listing) new · filed 2025-07-24 | 15.8% |
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| CITIGROUP INC 0.00% of their portfolio | 337.8k $1.5m | Added +313.7k |
| Corbin Capital Partners, L.P. 1.05% of their portfolio | 260.1k $1.1m | New |
| Atalaya Capital Management LP 0.16% of their portfolio | 73.7k $322.3k | New |
| MORGAN STANLEY 0.00% of their portfolio | 40.3k $176.1k | Added +21.7k |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 39.2k $171.2k | Reduced -19.4k |
| ProVise Management Group, LLC 0.01% of their portfolio | 35.1k $153.3k | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 33.1k $144.5k | Added +6.5k |
| Grey Street Capital, LLC 0.05% of their portfolio | 23.3k $101.9k | New |
| LEVIN CAPITAL STRATEGIES, L.P. 0.01% of their portfolio | 20.0k $87.4k | New |
| Circle Wealth Management, LLC 0.01% of their portfolio | 14.5k $63.4k | Unchanged |
| Tuttle Capital Management, LLC 0.02% of their portfolio | 12.2k $4.8k | New |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 10.8k $47.2k | Unchanged |
| Summit Trail Advisors, LLC 0.00% of their portfolio | 10.3k $44.9k | New |
| Financial Guidance Group, Inc. 0.03% of their portfolio | 10.3k $44.8k | Unchanged |
| Opal Wealth Advisors, LLC 0.02% of their portfolio | 10.0k $43.7k | Unchanged |
| Steward Partners Investment Advisory, LLC 0.00% of their portfolio | 6.0k $26.4k | Unchanged |
| Tower View Wealth Management LLC 0.02% of their portfolio | 5.6k $24.0k | Unchanged |
| Activest Wealth Management 0.02% of their portfolio | 4.1k $28.4k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.5k $7.0k | Unchanged |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 780 $3.4k | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |